Manufacturer record
Cipco Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Cipco Pharmaceuticals (Madhya Pradesh) were declared Not of Standard Quality between January 2019 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Cipco Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron & Folic Acid Tablets IP | IFS250104Mfg 2025-01 · Exp 2026-12 | The sample is not of standard quality for the reason stated under Description.Description | RDTL,GuwahatiCDSCO lab | Jan 2026 |
| Cetirizine Tablets IP 10 mg | C2180801Mfg 2018-08 · Exp 2020-07 | Related Substances & AssayAssay | CDTL MumbaiCDSCO lab | Mar 2019 |
| Paracetamol Tablets I.P. 500 mg | PC170309Mfg 2017-03 · Exp 2019-02 | Uniformity of weight and DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.